Company Valuation: Basilea Pharmaceutica AG

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 484.7 545.8 422.9 501.2 672.1 903.4 - -
Change - 12.62% -22.52% 18.52% 34.1% 34.4% - -
Enterprise Value (EV) 1 552.8 630 473.9 472.6 585.2 736.1 673.2 641.8
Change - 13.97% -24.78% -0.28% 23.84% 25.78% -8.55% -4.66%
P/E -70.6x 44.9x 41x 7.09x 17.4x 11.2x 15.4x 48.8x
PBR - - -42.3x 6.17x 5.26x 4.43x 3.3x 3.28x
PEG - -0x -2.6x 0x -0.4x 0x -0.6x -0.7x
Capitalization / Revenue 3.27x 3.69x 2.68x 2.4x 2.89x 3.07x 3.19x 4.4x
EV / Revenue 3.73x 4.26x 3.01x 2.27x 2.52x 2.5x 2.38x 3.13x
EV / EBITDA 287x 32.1x 22.8x 7.51x 11x 7.48x 10.2x 33.1x
EV / EBIT 461x 34.1x 24.7x 7.72x 11.4x 6.36x 10.1x 37.9x
EV / FCF -16.8x 168x 35.9x 6.51x 9.88x 8.66x 11.7x 48.6x
FCF Yield -5.94% 0.6% 2.79% 15.4% 10.1% 11.5% 8.53% 2.06%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -0.58 1.02 0.86 5.83 3.14 6.491 4.73 1.489
Distribution rate - - - - - - - -
Net sales 1 148.1 147.8 157.6 208.5 232.4 294.1 283.1 205.3
EBITDA 1 1.926 19.64 20.78 62.91 53.36 98.42 66.17 19.36
EBIT 1 1.2 18.5 19.2 61.2 51.5 115.8 66.41 16.92
Net income 1 -6.8 12.15 10.5 77.6 40.2 111.3 74.91 -
Net Debt 1 68.1 84.17 50.98 -28.65 -86.9 -167.3 -230.2 -261.6
Reference price 2 40.92 45.80 35.30 41.35 54.70 72.70 72.70 72.70
Nbr of stocks (in thousands) 11,844 11,918 11,980 12,121 12,288 12,426 - -
Announcement Date 15/02/22 14/02/23 13/02/24 18/02/25 17/02/26 - - -
1CHF in Million2CHF
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
11.2x2.5x7.48x-.--% 1.07B
17.12x6.54x12.53x1.74% 65.42B
31.85x8.5x28.11x0.07% 58.91B
38.62x6.88x20.55x0.84% 55.24B
41.79x5.95x28.33x-.--% 45.66B
32.7x3.15x13.61x-.--% 41.29B
36.32x8.98x23.42x0.36% 36.82B
-18.89x54.48x-20.65x-.--% 34.48B
41.53x8.01x26.87x-.--% 32.5B
-89.49x16.75x-96.22x-.--% 31.69B
Average 14.28x 12.17x 4.40x 0.3% 40B
Weighted average by Cap. 18.85x 11.69x 8.55x 0.44%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Basilea Pharmaceutica AG

Historical PBR trend

Valuation ratios - PBR - Basilea Pharmaceutica AG

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Basilea Pharmaceutica AG

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Basilea Pharmaceutica AG


Year-on-year evolution of the Yield

Valuation ratios - Yield - Basilea Pharmaceutica AG
  1. Stock Market
  2. Stocks
  3. BSLN Stock
  4. Valuation Basilea Pharmaceutica AG